Pfizer Documents (PHMPT/FDA)
· Pfizer Bla Submission
/ Pfizer 16 Plus Documents
· 4 pages
How To Review Ads: Responsive Search Ads leverage a set of approved headlines and descriptions to generate combinations of ads Up-to 15 headlines and 4 descriptions can be approved Based on machine learning, the Search Engine will identify the best combination to show the searcher Information that will always show in the ad is listed as "PINNED" Ads can show as follow: Example: Character Limits: Headline 1 | Headline 2 | Headline 3 Max 30 | Max 30 | Max 30 Display URL/path1/path2 No limit on…
Pfizer Documents (PHMPT/FDA)
· Pfizer Bla Submission
/ Pfizer 16 Plus Documents
· 2 pages
FDA-CBER-2021 5683 0951979 D gi a ly signed by DN c= o Pf zer Inc. ou=PPLS - College lle ou=Submissions and Operations Support cn Reason I am signing on behalf Donna Boyce Location Date 2021 10.01 12 20 51 0 '00' (b) (6) (b) (6) (b) (6) (b) (6) (b) (6) FDA-CBER-2021-5683-0951980
Pfizer Documents (PHMPT/FDA)
· Pfizer Bla Submission
/ Pfizer 16 Plus Documents
· 20 pages
1HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use COMI RNATY safely and effectively. See full prescribing information for COMIRNATY . COMIRNATY®(COVID -19 Vaccine , mRNA )suspension for injection , for intramuscular use Initial U.S. Approval: 2021 --------------------------- INDICATIONS AND USAGE ---------------------------- COMI RNATY is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVI D-19) caused…
Pfizer Documents (PHMPT/FDA)
· Pfizer Bla Submission
/ Pfizer 16 Plus Documents
· 38 pages
FDA-CBER-2021-5683-0950675 FDA-CBER-2021-5683-0950676 FDA-CBER-2021-5683-0950677 FDA-CBER-2021-5683-0950678 FDA-CBER-2021-5683-0950679 FDA-CBER-2021-5683-0950681 FDA-CBER-2021-5683-0950682 FDA-CBER-2021-5683-0950683 FDA-CBER-2021-5683-0950684 FDA-CBER-2021-5683-0950685 FDA-CBER-2021-5683-0950687 FDA-CBER-2021-5683-0950688 FDA-CBER-2021-5683-0950689 FDA-CBER-2021-5683-0950690 FDA-CBER-2021-5683-0950691 FDA-CBER-2021-5683-0950692 FDA-CBER-2021-5683-0950693 FDA-CBER-2021-5683-0950694…
Pfizer Documents (PHMPT/FDA)
· Pfizer Bla Submission
/ Pfizer 16 Plus Documents
· 4 pages
Upon clcking, downoads to PP CVV USA-03891 FDA-CBER-2021-5683-0952057 Summary of Comments on pp-cvv-usa-0429.pdf Page: 1 Number: 1 Author: oliviamassey Subject: CalloutDate: 9/28/2021 11:50:39 AM Upon clicking, downloads to PP-CVV-USA-0389 FDA-CBER-2021-5683-0952058 Upon clicking, downloads to PP-CVV-USA-0387Upon clicking, downloads to PP-CVV-USA-03891 2 FDA-CBER-2021-5683-0952059 Page: 2 Number: 1 Author: oliviamassey Subject: CalloutDate: 9/28/2021 11:55:27 AM Upon clicking,…
Pfizer Documents (PHMPT/FDA)
· Pfizer Bla Submission
/ Pfizer 16 Plus Documents
· 2 pages
FDA-CBER-2021 5683 0952061 D gi a ly signed by DN c o=Pf zer Inc. ou=PPLS - ou Subm ss ons and Operations Support cn Reason I am s gning on beha f of Donna Boyce Locat on Da e 2021.1 .06 6 11 1 0800 (b) (6) (b) (6) (b) (6) (b) (6) (b) (6) (b) (6) (b) (6) FDA-CBER-2021-5683-0952062
Pfizer Documents (PHMPT/FDA)
· Pfizer Bla Submission
/ Pfizer 16 Plus Documents
· 20 pages
1HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use COMI RNATY safely and effectively. See full prescribing information for COMIRNATY . COMIRNATY®(COVID -19 Vaccine , mRNA )suspension for injection , for intramuscular use Initial U.S. Approval: 2021 --------------------------- INDICATIONS AND USAGE ---------------------------- COMI RNATY is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVI D-19) caused…
Pfizer Documents (PHMPT/FDA)
· Pfizer Bla Submission
/ Pfizer 16 Plus Documents
· 8 pages
1 Revised: 22September 2021VACCINE INFORMA TION FACT SHEET FOR REC IPIENTS AND CA REGIVERS ABOUT COMIRNA TY (COVID -19 VA CCINE, mRNA ) ANDPFIZER -BIONTECH COVID -19 VACCINE TO PREVENT CORONA VIRUS DISEA SE 2019 (COVID -19) You are being offered either COMIRNA TY (COVID -19 Vaccine, mRNA ) or the Pfizer-BioNTech COVID- 19 Vaccine to prevent Coronavirus Disease 2019 (COVID -19)caused by S ARS -CoV-2. This Vaccine Information Fact Sheet for Recipients and Caregivers comprises the Fact Sheet…
Pfizer Documents (PHMPT/FDA)
· Pfizer Bla Submission
/ Pfizer 16 Plus Documents
· 15 pages
1HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TRUMENBA safely and effectively. See full p rescribing information for TRUMENBA . TRUMENBA®(Meningococcal Group B Vaccine ) Suspension for intramuscular injection Initial U.S. Approval: 2014 ------------------------ ----INDICATIONS AND USAGE --------------------------- Trumenba is indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B…
Pfizer Documents (PHMPT/FDA)
· Pfizer Bla Submission
/ Pfizer 16 Plus Documents
· 18 pages
1HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PREVNAR 20 safely and effectively. See full prescribing information for PREVNAR 20. PREVNAR 20 (Pneumococcal 20-valent Conjugate Vaccine) , suspension for intramuscular injection Initial U.S. Approval: 2021 --------------------------- INDICATIONS AND USAGE ---------------------------- Prevnar 20 isa vaccine indicated for active immunization for the prevention of pneumonia and invasive…
Pfizer Documents (PHMPT/FDA)
· Pfizer Bla Submission
/ Pfizer 16 Plus Documents
· 20 pages
1HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use COMI RNATY safely and effectively. See full prescribing information for COMIRNATY . COMIRNATY®(COVID -19 Vaccine , mRNA )suspension for injection , for intramuscular use Initial U.S. Approval: 2021 --------------------------- INDICATIONS AND USAGE ---------------------------- COMI RNATY is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVI D-19) caused…
Pfizer Documents (PHMPT/FDA)
· Pfizer Bla Submission
/ Pfizer 16 Plus Documents
· 8 pages
Pfizer logo in Champion Sponsorship area. With this option the User will skip the Association Profile Page and go directly to the Pfizer Unbranded Landing Page.Prevnar 20 tile presented on page 6 was submitted as part of a subpart E submission under job code PP -PNR- USA-0049 FDA-CBER-2021-5683-0951433 Site Map Please reference page 6 for linking informationPlease reference page 5 for linking information FDA-CBER-2021-5683-0951434 Association Exhibit Listing -Champion sponsorship within…
Pfizer Documents (PHMPT/FDA)
· Pfizer Bla Submission
/ Pfizer 16 Plus Documents
· 2 pages
FDA-CBER-2021 5683 0951441 Digitally signed by DN o=Pfizer Inc cn Reason I am signing on behalf of Donna Boyce Location Date 2021.09.01 1 23 29 0800' (b) (6) (b) (6) (b) (6) (b) (6) FDA-CBER-2021-5683-0951442
Pfizer Documents (PHMPT/FDA)
· Pfizer Bla Submission
/ Pfizer 16 Plus Documents
· 8 pages
PFIZER Pfizer-BioNTech COVID -19 Vaccine, also known as COMIRNATY® IVR & Live Operator Script Greetings PP-CVV -USA-0378 877-829-2619 (877-VAX -CO19) PP-CVV-USA-0378_Pfizer-BioNTech Covid-19 Vaccine also known as Comirnaty_IVR and Live Operator Script_Greetings Page 1 of 6 Confidential Pfizer document - for internal use only. Reproduction and/or distribution of this document for any purpose without express written consent…
Pfizer Documents (PHMPT/FDA)
· Pfizer Bla Submission
/ Pfizer 16 Plus Documents
· 3 pages
COVID-19 Vaccine (BNT162, PF -07302048) BLA 125 742 1.12.4 Request for Comments and Advice PFIZER CONFIDENTIAL Page 1REQUEST FOR COMMENTS AND ADVICE COVID-19 VACCINE ( PF-07302048 ) POSTMARKETING ADVERS E EVENT REPORTING SEPTEMBER 2021 090177e197fb0030\Approved\Approved On: 03-Sep-2021 13:06 (GMT) FDA-CBER-2021-5683-0951451 COVID-19 Vaccine (BNT162, PF -07302048) BLA 125 742 1.12.4 Request for Comments and Advice PFIZER CONFIDENTIAL Page 21.INTRODUCTION Reference is made to the Biologics…
Pfizer Documents (PHMPT/FDA)
· Pfizer Bla Submission
/ Pfizer 16 Plus Documents
· 2 pages
Pfizer Global Regulatory Affairs Pfizer Inc. 235 East 42ndStreet/New York , NY 10017 -5755 Global Product Developm ent 07September 2021 Marion Gruber, Ph.D. Director Office of Vaccines Research and Review Food and Drug Administration Center for Biologics Evaluation and Research DocumentControl Center 10903 New Hampshire Avenue WO71, G112 Silver Spring, MD 20993 -0002THIS DOCUMENT CONTAINS CONFIDENTIAL AND/OR TRADE SECRET INFORMATION THAT IS DISCLOSED ONLY IN CONNECTION WITH THE LICENSING…
Pfizer Documents (PHMPT/FDA)
· Pfizer Bla Submission
/ Pfizer 16 Plus Documents
· 2 pages
FDA-CBER-2021 5683 0951456 D gi a ly signed by DN o Pf zer Inc. ou=PPLS - College lle ou=Submissions and Operations Support cn Reason I am signing on behalf Donna Boyce Location Date 2021 09.08 10 56 35 0 '00' (b) (6) (b) (6) (b) (6) (b) (6) (b) (6) FDA-CBER-2021-5683-0951457
Pfizer Documents (PHMPT/FDA)
· Pfizer Bla Submission
/ Pfizer 16 Plus Documents
· 8 pages
1 Revised: 01September 2021VACCINE INFORMA TION FACT SHEET FOR REC IPIENTS AND CA REGIVERS ABOUT COMIRNA TY (COVID -19 VA CCINE, mRNA ) ANDPFIZER -BIONTECH COVID -19 VACCINE TO PREVENT CORONA VIRUS DISEA SE 2019 (COVID -19) You are being offered either COMIRNA TY (COVID -19 Vaccine, mRNA ) or the Pfizer-BioNTech COVID- 19 Vaccine to prevent Coronavirus Disease 2019 (COVID -19)caused by S ARS -CoV-2. This Vaccine Information Fact Sheet for Recipients and Caregivers comprises the Fact Sheet…
Pfizer Documents (PHMPT/FDA)
· Pfizer Bla Submission
/ Pfizer 16 Plus Documents
· 41 pages
Revised: 01 September 2021 1 FACT SHEET FOR HEALTHCARE PROVIDERS ADMINISTERING VACCINE (VACCINATION PROVIDERS) EMERGENCY USE AUTHORIZATION (EUA) OF THE PFIZER -BIONTECH COVID -19 VACCINE TO PREVENT CORONAVIRUS DISEASE 2019 (COVID -19) The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved product, Pfizer -BioNTech COVID -19 Vaccine , for active immunization to prevent COVID -19 in individuals 12…
Pfizer Documents (PHMPT/FDA)
· Pfizer Bla Submission
/ Pfizer 16 Plus Documents
· 20 pages
1HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use COMI RNATY safely and effectively. See full prescribing information for COMIRNATY . COMIRNATY®(COVID -19 Vaccine , mRNA )suspension for injection , for intramuscular use Initial U.S. Approval: 2021 --------------------------- INDICATIONS AND USAGE ---------------------------- COMI RNATY is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVI D-19) caused…